21 Aug 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-08-21/bausch-health-canada-inc-treatment-for-acne-vulgaris-pr-cabtreo-tm-clindamycin-phosphate-adap
21 May 2025
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-21-2025-89397.pdf
17 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/17/3063410/0/en/Sol-Gel-and-Mayne-Pharma-Announce-the-Purchase-of-EPSOLAY-and-TWYNEO-in-the-U-S.html
26 Mar 2025
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-26-2025-60230.pdf
18 Nov 2024
// ACCESSWIRE
https://www.accesswire.com/943498/prcabtreotm-clindamycin-phosphate-adapalene-and-benzoyl-peroxide-gel-treatment-for-acne-vulgaris-receives-positive-reimbursement-recommendations-from-canadas-drug-agency-and-quebecs-inesss
11 Sep 2024
// ACCESSWIRE
https://www.accesswire.com/915793/health-canada-approves-prcabtreotm-clindamycin-phosphate-adapalene-and-benzoyl-peroxide-triple-combination-topical-treatment-for-acne-vulgaris-in-patients-12-years-of-age-and-older